Based on the xLinkAb model, FcγRIIB dependent TNFRSF agonistic antibodies would show optimal agonistic activity in a tumor microenvironment where both co-stimulation target TNFRSF and FcγRIIB are present on infiltrating immune cells and readily available for interaction. Here, FCGR2B is linked to neoplasm.